In 2025, Category III codes 0913T and 0914T were introduced to streamline the reporting of percutaneous coronary interventions (PCI) by combining drug-coated balloon (DCB) angioplasty with advanced imaging techniques like intravascular ultrasound (IVUS) or optical coherence tomography (OCT). DCB angioplasty is a minimally invasive technique delivering antiproliferative drugs directly to narrowed or blocked arteries, promoting long-term vessel patency without permanent implants. These new codes reflect the growing role of innovative, precise therapies in coronary artery disease (CAD) management, ensuring accurate documentation and facilitating optimal reimbursement. Understanding key nuances is critical for correct and compliant coding come 2025. Let’s examine the details to score success now and throughout the new year.
Critical Understanding of Coronary Intervention via Drug Delivery Balloon
First, we need to understand what makes each code selection unique. Let’s start with Code 0913T. Code 0931T details PCI utilizing drug-eluting or drug-coated angioplasty and includes mechanical dilation with a non-drug delivery balloon and IVUS or OCT, when performed, on a major coronary artery or graft (left main, LAD, LCX, RCA, ramus intermedius) or a branch of the major coronary artery (LAD, LCX, RCA).
| 0913T | Percutaneous transcatheter therapeutic drug delivery by intracoronary drug-delivery balloon (eg, drug-coated, drug-eluting), including mechanical dilation by nondrug-delivery balloon angioplasty, endoluminal imaging using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) when performed, imaging supervision, interpretation, and report, single major coronary artery or branch |
Code 0914T, however, is an add-on code. This code encompasses PCI utilizing drug-eluting or drug-coated angioplasty and includes mechanical dilation with a non-drug delivery balloon and IVUS or OCT, when performed. It is important to note this add-on code is reported when performed on a separate target lesion in addition to the primary intervention in the same major coronary artery or graft (left main, LAD, LCX, RCA, ramus intermedius) or a branch of the major coronary artery (LAD, LCX, RCA).
| +0914T | Percutaneous transcatheter therapeutic drug delivery by intracoronary drug-delivery balloon (eg, drug-coated, drug-eluting) performed on a separate target lesion from the target lesion treated with balloon angioplasty, coronary stent placement or coronary atherectomy, including mechanical dilation by nondrug-delivery balloon angioplasty, endoluminal imaging using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) when performed, imaging supervision, interpretation, and report, single major coronary artery or branch (List separately in addition to code for percutaneous coronary stent or atherectomy intervention) |
For accurate coding, coders must hold a clear understanding of the procedure itself. Percutaneous transcatheter therapeutic drug delivery by intracoronary drug-coated balloon (DCB) is a minimally invasive procedure used to treat coronary artery disease (CAD). It involves using a specialized balloon catheter to deliver antiproliferative drugs directly to the site of a narrowed or blocked coronary artery during percutaneous coronary interventions (PCI). This approach can be combined with other interventions aimed at restoring blood flow to the heart. DCBs provide long-term vessel patency and may offer comparable outcomes to drug-eluting stents (DES) without the need for permanent implants, making them a valuable option, particularly for in-stent restenosis cases.
With every dollar of reimbursement counting more than ever in the face of payment decline and complex new rules, it’s imperative to make sure your CPT® coding is correct and compliant. Master more cardiology coding topics and break down the complexity with our Cardiology All Access Pass. Find the right subscription and resource tailored to your needs today to make every member of your team successful with 2025 coding.
The Medicare Advantage (MA) program has grown significantly over the past two decades, becoming a popular alternative to traditional Medicare fee-for-service (FFS). As of 2023,
The Medicare and Medicaid provider auditing process is about to get a makeover in 2025. I am talking about artificial intelligence (AI), which may be
Please log in to your account to comment on this article.
Join Beth Wolf, MD, CPC, CCDS, for an in-depth webcast on the FY2025 spinal fusion MS-DRG updates. Discover key changes in DRG classification, understand impacts on documentation and CMI, and learn strategies to ensure compliance.
Join Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, as she presents effective strategies to strengthen collaboration between CDI, coding, and quality departments in acute care hospitals. Angela will also share guidance on implementing cross-departmental meetings, using shared KPIs, and engaging leadership to foster a culture of collaboration. Attendees will gain actionable tools to optimize documentation accuracy, elevate quality metrics, and drive a unified approach to healthcare goals, ultimately enhancing both patient outcomes and organizational performance.
Optimize your outpatient clinical documentation and gain comprehensive knowledge from foundational practices to advanced technologies, ensuring improved patient care and organizational and financial success. This webcast bundle provides a holistic approach to outpatient CDI, empowering you to implement best practices from the ground up and leverage advanced strategies for superior results. You will gain actionable insights to improve documentation quality, patient care, compliance, and financial outcomes.
Enhancing outpatient clinical documentation is crucial for maintaining accuracy, compliance, and proper reimbursement in today’s complex healthcare environment. This webcast, presented by industry expert Angela Comfort, DBA, RHIA, CDIP, CCS, CCS-P, will provide you with actionable strategies to tackle complex challenges in outpatient documentation. You’ll learn how to craft detailed clinical narratives, utilize advanced EHR features, and implement accurate risk adjustment and HCC coding. The session also covers essential regulatory updates to keep your documentation practices compliant. Join us to gain the tools you need to improve documentation quality, support better patient care, and ensure financial integrity.
Dr. Ronald Hirsch provides critical details on the new Medicare Appeal Process for Status Changes for patients whose status changes during their hospital stay. He also delves into other scenarios of hospital patients receiving custodial care or medically unnecessary services where patient notifications may be needed along with the processes necessary to ensure compliance with state and federal guidance.
Healthcare organizations face complex regulatory requirements under the No Surprises Act and Price Transparency rules. These policies mandate extensive fee disclosures across settings, and confusion is widespread—many hospitals remain unaware they must post every contracted rate. Non-compliance could lead to costly penalties, financial loss, and legal risks. Join David M. Glaser Esq. as he shows you how to navigate these regulations effectively.
Protect your facility from unwanted audits! Join Becky Jacobsen, BSN, RN, MBS, CCS-P, CPC, CPEDC, CBCS, CEMC, and take a deep dive into both the CMS and AMA guidelines for reporting post operative pain blocks. You’ll learn how to determine if the nerve block is separately codable with real life examples for better understanding. Becky will also cover how to evaluate whether documentation supports medical necessity, offer recommendations for stronger documentation practices, and provide guidance on educating providers about documentation requirements. She’ll include a discussion of appropriate modifier and diagnosis coding assignment so that you can be confident that your billing of post operative pain blocks is fully supported and compliant.
During this RACmonitor webcast Dr. Ronald Hirsch spotlights the areas of the OIG’s Work Plan and the findings of their most recent audits that impact utilization review, case management, and audit staff. He also provides his common-sense interpretation of the prevailing regulations related to those target issues. You’ll walk away better equipped with strategies to put in place immediately to reduce your risk of paybacks, increased scrutiny, and criminal penalties.
Copyright © 2024 RACmonitor. Powered by MedLearn Media.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
